Rie Ogawa

Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019

T. Kuwahara, Shinji Watanabe, Kazuya Nakamura, 2019, Emerging infectious diseases.

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018

T. Kuwahara, Shinji Watanabe, Kazuya Nakamura, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza A(H3N2) virus exhibiting reduced susceptibility to baloxavir due to a polymerase acidic subunit I38T substitution detected from a hospitalised child without prior baloxavir treatment, Japan, January 2019

T. Kuwahara, Shinji Watanabe, Kazuya Nakamura, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Effects of Indoxylsulfate on the in vitro Hepatic Metabolism of Various Compounds Using Human Liver Microsomes and Hepatocytes

K. Hanada, H. Ogata, K. Son, 2006, Nephron Physiology.

Influence of lifestyle‐related diseases and age on the development and progression of non‐alcoholic fatty liver disease

T. Okanoue, A. Umemura, Kojiro Seki, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.

G. Neumann, Y. Kawaoka, M. Tashiro, 2016, Antiviral research.

Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil

Shinji Watanabe, Kazuya Nakamura, N. Kishida, 2018, Front. Microbiol..

Rapid detection of an I38T amino acid substitution in influenza polymerase acidic subunit associated with reduced susceptibility to baloxavir marboxil

Shinji Watanabe, Shinji Saito, T. Odagiri, 2019, Influenza and other respiratory viruses.